Dr. Wolchok is an assistant attending physician at Memorial Sloan-Kettering Cancer Center (MSKCC) with expertise in the treatment of metastatic melanoma. His specific area research interest is the preclinical and early clinical development of novel immunologic therapies. Most recently, Dr. Wolchok has initiated several clinical trials using plasmid DNA vaccines for patients with melanoma. He has been involved in the development of the DNA vaccine program at every level—from initial studies in mouse models, through all levels of regulatory review, and now as Principal Investigator of the clinical trials. Dr. Wolchok has authored numerous articles concerning DNA vaccines, cytokine biology, and clinical care of melanoma, and coauthored two chapters in the definitive textbook, Cutaneous Melanoma. Dr. Wolchok is also coeditor of the journal Cytotherapy. Most recently, Dr. Wolchok was appointed to be Associate Director of the Ludwig Center for Cancer Immunotherapy at MSKCC.